Date: 07 Feb 2025
Hall A |
| Time |
Topic |
Speaker |
Chairpersons |
| 14:00 - 15:00 |
HYPERTROPHIC CARDIOMYOPATHY - FOCUS SESSION
|
|
|
| 14:00 - 14:10 |
DIAGNOSIS OF HCM IN 2025
|
Manokar P |
|
| 14:10 - 14:20 |
GENETIC MARKERS-WHAT DOES IT OFFER IN HCM
|
Hisham Ahamed |
|
| 14:20 - 14:30 |
INTERVENTION TREATMENT-CURRENT STRATEGIES
|
K H Srinivas |
|
| 14:30 - 14:40 |
ROLE OF SURGEON IN HCM
|
Praveen Varma |
|
| 14:40 - 14:55 |
NEW HORIZONS IN HF THERAPY: MYOSIN INHIBITORS - MAVACAMTEN
|
Bhagirath Raguraman |
|
| 14:55 - 15:00 |
Break (a7-2.55) |
|
|
| 15:00 - 16:00 |
HF THERAPY - THE FUTURE BECKONS
|
|
|
| 15:00 - 15:10 |
AI IN HF DIAGNOSIS AND TREATMENT - IS IT THE FUTURE?
|
Anil Balachandran |
|
| 15:10 - 15:20 |
PA PRESSEURE MONITORING IN HF-HOW RELEVANT IT IS IN PRACTICE?
|
JAI SHANKAR KRISHNAMOORTHY |
|
| 15:20 - 15:30 |
ANTI-INFLAMMATORY TREATMENT IN HEART FAILURE
|
KMK REDDY |
|
| 15:30 - 15:40 |
GENE THERAPY
|
Sandeep Seth |
|
| 15:40 - 15:52 |
ADVANCED IMAGING IN HEART FAILURE: WHERE ARE WE IN 2025?
|
CHANDRASEKHAR Y |
|
| 15:52 - 16:00 |
break (A7-3.53) |
|
|
| 16:00 - 16:30 |
CHANGING CONCEPTS IN THERAPY
|
|
|
| 16:00 - 16:15 |
OUT OF HOSPITAL, NOT OUT OF RISK: A REAL-WORLD PERSPECTIVE IN INDIAN CLINICAL SETTINGS
|
Refai Sowkath Ali |
|
| 16:15 - 16:30 |
DYSLIPIDEMIA IN HF & CAD - NEWER APPROACHES
|
RAJESH T |
|
| 16:30 - 17:30 |
ALL ABOUT HFpEF
|
|
|
| 16:30 - 16:40 |
PHENOTYPING-RELEVANCE
|
Shanmughasudharam. S |
|
| 16:40 - 16:50 |
ECHO TO UNLOCK THE MYSTERY
|
Sameer Shrivastava |
|
| 16:50 - 17:00 |
A DEEP DIVE INTO THE LA INDICES
|
Chandrasekhar Kashinath Ponde |
|
| 17:00 - 17:10 |
SGLT2 OR GLP IN HFpEF
|
Santhosh Satheesh |
|
| 17:10 - 17:25 |
STRATEGY TO PREVENT HFpEF IN AGING SOCIETY
|
KOJI HASEGAWA |
|
| 17:25 - 17:30 |
WRAP UP
|
BRENDA MOURA |
|
| 17:30 - 18:30 |
AHS HFAI JOINT SESSION - HF THERAPY IN ASIA - CHALLENGES & SOLUTIONS
|
|
|
| 17:30 - 17:35 |
INTRODUCTION - HF THERAPY IN ASIA
|
Mrinal Kanti Das |
|
| 17:35 - 17:45 |
HF - ARE ASIANS DIFFERENT
|
George Koshy A |
|
| 17:45 - 17:55 |
HF - ARE WOMEN DIFFERENT
|
XIN DU (CHINA) |
|
| 17:55 - 18:05 |
ADDRESSING THERAPY OF HF - THE WAY FORWARD
|
Veena Nanjappa |
|
| 18:05 - 18:15 |
IRON DEFICIENCY IN HF
|
JINGYN REN (CHINA) |
|
| 18:15 - 18:30 |
PANEL DISCUSSION
|
|
|
| 18:30 - 19:30 |
PRIME TIME SYMPOSIUM
|
|
|
| 18:30 - 18:45 |
HYPOTENSION ON ARNI-THE CHANGING CONCEPTS (REDDYS)
|
SOUMITRA RAY |
|
| 18:45 - 19:00 |
ARNI IN HFPEF-WHO NEEDS IT?
|
Chandrasekhar Kashinath Ponde |
|
| 19:00 - 19:15 |
EARLY ADOPTION OF MRA'S IN HF AND MANAGING HYPERKALEMIA (CIPLA)
|
THERESA McDONAGH |
|
| 19:15 - 19:30 |
PREVENTION OF HF/STAGE A AND STAGE B HEART FAILURE: NEW LESSONS FROM IMAGING
|
CHANDRASEKHAR Y |
|
| 19:30 - 20:30 |
HF - FROM PREVENTION TO MANAGEMENT
|
|
|
| 19:30 - 19:45 |
EPICARDIAL ADIPOSE TISSUE IN HEART FAILURE: RISK FACTOR OR MEDIATOR?
|
Shantanu Sengupta |
|
| 19:45 - 19:55 |
THE EARLY PREDICTION OF HF IN DIABETES
|
RAVINDRANATH KS |
|
| 19:55 - 20:05 |
VACCINES IN HF PRACTICE
|
Mrinal Kanti Das |
|
| 20:05 - 20:15 |
NEW IMAGING INSIGHTS TO CARDIOMYOPATHY
|
SUVRO BANERJEE |
|
| 20:15 - 20:25 |
DIGOXIN IN HF - IS IT THE END OF THE ROAD?
|
Niteen V.Deshpande |
|
| 20:25 - 20:30 |
DISCUSSION
|
|
|
| 20:29 - 20:44 |
REDEFINING CVS PROTECTION: NOVEL APPROACHES FOR HIGH-RISK PATIENTS
|
Mohanan P P |
|
| 20:44 - 21:44 |
EXECUTIVE COMMITTEE MEETING HFAI
|
|
|
| Adjourn |
